Differences

This shows you the differences between two versions of the page.

--- projects:workgroups:transfusion [2019/12/13 02:41] – cgreich
+++ projects:workgroups:transfusion [2019/12/13 04:05] (current) – cgreich
@@ Line 1: / Line 1: @@
 ==== OHDSI Transfusion Working Group ====
+<WRAP box justify round>
 === MISSION ===
@@ Line 6: / Line 8: @@
 Transfusions are special treatments which are currently in active research by the FDA BEST and the [[https://www.nhlbi.nih.gov/science/recipient-epidemiology-and-donor-evaluation-study-reds-program|REDS-IV]] program. The current OMOP CDM allows only partial capture of relevant transfusion information to support the various research use cases (see below). This Working Group intends to close that gap.
+</WRAP>
 == Use Cases ==
@@ Line 27: / Line 31: @@
    * monitoring: preparation, processing, mobilization, modification, quarantine,
    * Additive, excipient and nutrient content
+  * Dose
+  * Units
+  * Route
+  * Start/End Time
+  * Multiple touch points of interest (prescribe/dispense/admin)
+  * Lab results specific to the unit for unit-specific data (product CD34+ vs patient CD34+)
 * [[projects:workgroups:transfusion:members|Participants]]